Skip to content
(RS)-mitotane

Structure via PubChem · Public domain (PubChem)

EntityQ417465· pop 26· linked from 443 articles

(RS)-mitotane

Sign in to save

Also known as o,p′-DDD

Mitotane, sold under the brand name Lysodren, is a steroidogenesis inhibitor and cytostatic antineoplastic medication which is used in the treatment of adrenocortical carcinoma and Cushing's syndrome. It is a derivative of the early insecticide DDT and an isomer of (4,4'-dichlorodiphenyldichloroethane) and is also known as '''2,4'-(dichlorodiphenyl)-2,2-dichloroethane (o,p'-DDD''').

Chemical data

Formula
C14H10Cl4
Molecular weight
320 g/mol
IUPAC name
1-chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene
SMILES
C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl
InChIKey
JWBOIMRXGHLCPP-UHFFFAOYSA-N
XLogP
6.2
Polar surface area
0 Ų
H-bond donors
0
H-bond acceptors
0
Formal charge
0

via PubChem

Wikidata facts

Mass
317.95366104
Show 3 more facts
chemical formula
C₁₄H₁₀Cl₄
canonical SMILES
C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl
Commons category
Mitotane
Sources (5)

via Wikidata · CC0

~4 min read

Article

13 sections
Contents
  • Medical uses
  • Side effects
  • Pharmacology
  • Pharmacodynamics
  • Chemistry
  • History
  • Society and culture
  • Generic names
  • Brand names
  • Veterinary use
  • References
  • Further reading
  • External links

Mitotane, sold under the brand name Lysodren, is a steroidogenesis inhibitor and cytostatic antineoplastic medication which is used in the treatment of adrenocortical carcinoma and Cushing's syndrome. It is a derivative of the early insecticide DDT and an isomer of (4,4'-dichlorodiphenyldichloroethane) and is also known as '''2,4'-(dichlorodiphenyl)-2,2-dichloroethane (o,p'-DDD''').

==Medical uses== Mitotane has been produced by Bristol Myers Squibb but it is marketed as an orphan drug for adrenocortical carcinoma due to the small number of patients in need of it. Its main use is in those patients who have persistent disease despite surgical resection, those who are not surgical candidates, or those who have metastatic disease. In a 2007 retrospective study of 177 patients from 1985 to 2005 showed a significant increase in the recurrence-free interval after radical surgery followed by mitotane when compared to surgery alone. The drug is also sometimes used in the treatment of Cushing's syndrome.

Connections

Categories